- Nexalin Technology, Inc. faced delisting from Nasdaq due to failing to maintain a minimum bid price of $1.00 for 30 consecutive business days and not meeting a $5 million stockholders’ equity requirement.
- The company has requested a hearing to appeal the delisting while presenting a plan to regain compliance, which may involve a reverse stock split.
- Analysts currently rate NXL stock as a Buy with a target price of $2.00, but the outcome of the appeal remains uncertain, posing risks for investors.